GENOVESE DRUG STORES, INC. – Trademark Portfolio
Entity Type: 03
GENOVESE DRUG STORES, INC. has 79 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Filings span 20 Nice Classification classes, led by Class 42 (Computer & Scientific) and Class 3 (Cosmetics & Cleaning). This trademark owner is based in LONG ISLAND CITY, NY.
40-15 31ST AVE.
LONG ISLAND CITY, NY 11103
Showing of trademarks Trademarks
Trademark Classifications
GENOVESE DRUG STORES, INC.'s trademark portfolio spans 20 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying
Frequently Asked Questions
How many trademarks does GENOVESE DRUG STORES, INC. have?
GENOVESE DRUG STORES, INC. has 79 U.S. trademarks filed with the USPTO.
What trademark classes does GENOVESE DRUG STORES, INC. file in?
GENOVESE DRUG STORES, INC. files trademarks across 20 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 16 (Paper Goods). Class 42 covers scientific and technological services; industrial analysis and research services.
What is GENOVESE DRUG STORES, INC.'s trademark registration success rate?
GENOVESE DRUG STORES, INC. has a 0% trademark registration rate, with 0 out of 79 resolved applications resulting in successful registration. Currently, 0 applications are pending review.